Hualan Biological Engineering Inc
SZSE:002007
Hualan Biological Engineering Inc
SZSE:002007
Price:
14.95
CNY
1.29%
Market Closed
Market Cap:
¥27.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hualan Biological Engineering Inc
SZSE:002007
|
CN |
|
T
|
Toptec Co Ltd
KOSDAQ:108230
|
KR |
|
R
|
Redox Ltd
ASX:RDX
|
AU |
|
Marvel Discovery Corp
XTSX:MARV
|
CA |
|
Service Corporation International
NYSE:SCI
|
US |
Multiples-Based Value
The Multiples-Based Value of one
Hualan Biological Engineering Inc
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 14.95 CNY,
Hualan Biological Engineering Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hualan Biological Engineering Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Hualan Biological Engineering Inc Competitors
Hualan Biological Engineering Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Hualan Biological Engineering Inc
SZSE:002007
|
27.3B CNY | 5.9 | 29.1 | 18.4 | 18.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.4 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.5 | 40.5 | 41.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
